Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;156(3):443-452.
doi: 10.1007/s11060-021-03924-2. Epub 2022 Jan 20.

Leptomeningeal metastases: the future is now

Rimas V Lukas  1   2 , Jigisha P Thakkar  3 , Massimo Cristofanilli  4 , Sunandana Chandra  4 , Jeffrey A Sosman  4 , Jyoti D Patel  4 , Priya Kumthekar  5   6 , Roger Stupp  5   6   7 , Maciej S Lesniak  6   7
Affiliations
Review

Leptomeningeal metastases: the future is now

Rimas V Lukas et al. J Neurooncol. 2022 Feb.

Abstract

Leptomeningeal metastases (LM) constitute an involvement of cancer which is associated with marked morbidity and mortality. The contemporary diagnostic and therapeutic management of LM from solid tumors is reviewed. Therapeutic modalities including systemic therapies, cerebrospinal fluid (CSF)-directed therapies, and radiation therapy are discussed. This is to provide context for how the field of LM management may evolve in the near term. The future directions currently undergoing investigation for diagnostic, response assessment, and therapeutic purposes are highlighted. This is done within the context of the pathophysiology of the disease. Specifically the role of CSF circulating tumor cells and cell free circulating tumor DNA in diagnosis and response assement are reviewed. Novel therapeutic approaches across a range of modalities are discussed. Numerous ongoing studies which have the potential to alter the management of LM are referenced.

Keywords: CSF; Carcinomatous meningitis; Circulating tumor DNA; Intrathecal therapy; Leptomeningeal metastases.

PubMed Disclaimer

References

    1. Thakkar JP, Kumthekar P, Dixit KS, Stupp R, Lukas RV (2020) Leptomeningeal metastasis from solid tumors. J Neurol Sci 411:116706 - PubMed
    1. Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM (2010) Leptomeningeal metastases in the MRI era. Neurology 74(18):1449–1454 - PubMed - PMC
    1. Hyun JW, Jeong IH, Joung A, Cho HJ, Kim SH, Kim HJ (2016) Leptomeningeal metastasis: clinical experience of 519 cases. Eur J Cancer 56:107–114 - PubMed
    1. Glass JP, Melamed M, Chernik NL, Posner JB (1979) Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 29(10):1369–1375 - PubMed
    1. Lamba N, Wen PY, Aizer AA (2021) Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol 23(9):1447–1456 - PubMed

MeSH terms

LinkOut - more resources